Jennifer Rubatt, MD
Gynecologic Oncology · Loveland, CONPI 1831201540
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by GSK at 51.7% of the total. Reporting peaked in 2020 at $2,104 and has fallen 96.9% since, to $65 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in CO, where the typical reported total is $4,511.
Across 37 payments — averaging $121.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Intuitive Surgical$932
- Myriad Genetic Laboratories, Inc.$464
- Biom'up SA$150
- AbbVie$132
- Astellas Pharma US Inc$117
- plus $384 from 7 others
What the payments were for
- Consulting fees$1,95043%
- Travel & lodging$68515%
- Food & beverage$1,77739%
- Education$992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $2,331 |
| Intuitive Surgical | 5 | $932 |
| Myriad Genetic Laboratories, Inc. | 8 | $464 |
| Biom'up SA | 1 | $150 |
| AbbVie | 2 | $132 |
| Astellas Pharma US Inc | 2 | $117 |
| AstraZeneca | 5 | $100 |
| Medtronic | 2 | $89 |
| Merck | 3 | $80 |
| Stryker | 1 | $48 |
| Tactile Systems Technology Inc | 1 | $33 |
| Eisai Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$903
- ZEJULA$351
- HEMOBLAST$150
- PreciseTumor$128
- myChoice CDx$125
- myRisk$100
How this compares
$4,511 in reported general payments places this provider in the 50th percentile of 28 gynecologic oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Loveland
- Jeffrey JamesLone Tree$175K
- Bradley CorrAurora$70K
- Robin LacourGreeley$64K
- John CurtinDenver$42K
- Saketh GuntupalliAurora$39K
- Kevin DavisEnglewood$32K
- Glenn BigsbyLittleton$12K
- Carolyn LefkowitsAurora$11K
- Kian BehbakhtAurora$10K
- Christine WalshAurora$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.